This bill allows certain small businesses whose gross receipts do not exceed $1 million a refundable portion of the tax credit for increasing research activities if such businesses are engaging in specified medical research. It defines specified medical research as any qualified research with respect to qualified countermeasures. A qualified countermeasure is a drug, biological product, or device that is determined to be a priority (1) to diagnose, mitigate, prevent, or treat harm from any biological agent (including organisms that cause an infectious disease) or toxin, chemical, radiological, or nuclear agent that may cause a public health emergency affecting national security; (2) to diagnose, mitigate, prevent, or treat harm from a condition that may result in adverse health consequences or death and may be caused by administering a drug, biological product, or device; or (3) is a product or technology intended to enhance the use or effect of a drug, biological product, or device.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7556 Introduced in House (IH)]
<DOC>
116th CONGRESS
2d Session
H. R. 7556
To amend the Internal Revenue Code of 1986 to make a portion of
research credit refundable for certain small businesses engaging in
specified medical research.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
July 9, 2020
Mr. Nunes introduced the following bill; which was referred to the
Committee on Ways and Means
_______________________________________________________________________
A BILL
To amend the Internal Revenue Code of 1986 to make a portion of
research credit refundable for certain small businesses engaging in
specified medical research.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. REFUNDABLE PORTION OF RESEARCH CREDIT FOR SMALL BUSINESSES
ENGAGING IN SPECIFIED MEDICAL RESEARCH.
(a) In General.--Section 41 of the Internal Revenue Code of 1986 is
amended by adding at the end the following new subsection:
``(i) Refundable Portion for Small Businesses Engaging in Specified
Medical Research.--
``(1) In general.--At the election of a medical research
small business, the portion of the credit determined under this
section for the taxable year which is properly allocable to
specified medical research shall be treated (other than for
purposes of section 280C) as a credit allowed under subpart C
(and not this subpart).
``(2) Medical research small business.--For purposes of
this subsection, the term `medical research small business'
means any domestic C corporation--
``(A) which conducts any specified medical research
during the taxable year, and
``(B) the gross receipts of which (determined under
the rules of subsection (c)) for the taxable year do
not exceed $1,000,000.
``(3) Specified medical research.--For purposes of this
subsection, the term `specified medical research' means any
qualified research with respect to qualified countermeasures
(as defined in section 319F-1(a)(2) of the Public Health
Service Act (42 U.S.C. 247d-6a(a)(2)).
``(4) Election.--Any election under this subsection for any
taxable year--
``(A) shall specify the amount of the credit to
which such election applies,
``(B) shall be made on or before the due date
(including extensions) of the return of tax for the
taxable year,
``(C) may not be made for any taxable year with
respect to any portion of the credit determined under
this section with respect to which an election is made
under subsection (h), and
``(D) may be revoked only with the consent of the
Secretary.
``(5) Regulations.--The Secretary shall prescribe such
regulations for purposes of this subsection as may be necessary
or appropriate for determining proper allocation to specified
medical research of the portion of any credit allowed to a
taxpayer for a taxable year under this section.''.
(b) Conforming Amendment.--Section 1324(b) of title 31, United
States Code, is amended by inserting ``41(i),'' after ``6428,''.
(c) Effective Date.--The amendments made by this section shall
apply to taxable years beginning after December 31, 2020.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Ways and Means.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line